Prosecution Insights
Last updated: August 18, 2026

Examiner: NOBLE, MARCIA STEPHENS

Tech Center 1600 • Art Units: 1632

This examiner grants 67% of resolved cases

Performance Statistics

67.0%
Allow Rate
+7.0% vs TC avg
898
Total Applications
+40.3%
Interview Lift
1163
Avg Prosecution Days
Based on 851 resolved cases, 2023–2026

Rejection Statute Breakdown

7.2%
§101 Eligibility
15.8%
§102 Novelty
21.5%
§103 Obviousness
39.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18740453 DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY Non-Final OA President and Fellows of Harvard College
17544865 SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY Final Rejection California Institute of Technology
18635153 METHODS FOR REPROGRAMMING SOMATIC CELLS Non-Final OA Whitehead Institute for Biomedical Research
18060183 ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS Final Rejection Research Development Foundation
18327976 MURINE-MHC-DEFICIENT HLA-TRANSGENIC NOD-MOUSE MODELS FOR T1D THERAPY DEVELOPMENT Final Rejection The Jackson Laboratory

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month